dalteparin has been researched along with Peripheral Nerve Diseases in 1 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Klein, SM | 1 |
| D'Ercole, F | 1 |
| Greengrass, RA | 1 |
| Warner, DS | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Randomized Comparison Between Ultrasound Guided Lumbar Plexus and Suprainguinal Fascia Iliaca Blocks For Total Hip Replacement Analgesia[NCT03744065] | 60 participants (Actual) | Interventional | 2018-11-19 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 other study available for dalteparin and Peripheral Nerve Diseases
| Article | Year |
|---|---|
Enoxaparin associated with psoas hematoma and lumbar plexopathy after lumbar plexus block.
Topics: Aged; Anticoagulants; Enoxaparin; Female; Hematoma; Humans; Lumbosacral Plexus; Nerve Block; Periphe | 1997 |